%D9%85%D8%AA%D9%84%D8%A7%D8%B2%D9%85%D8%A9_%D9%85%D8%AA%D8%B9%D8%AF%D8%AF_%D8%A7%D9%84%D8%BA%D8%AF%D8%AF_%D8%A7%D9%84%D8%B5%D9%85_%D8%A8%D8%A7%D9%84%D9%85%D9%86%D8%A7%D8%B9%D8%A9_%D8%A7%D9%84%D8%B0%D8%A7%D8%AA%D9%8A%D8%A9_%D8%A7%D9%84%D9%86%D9%88%D8%B9_%D8%A7%D9%84%D8%A3%D9%88%D9%84Autoimmune_polyendocrine_syndrome_type_1Poliendocrinopat%C3%ADa_autoinmune_tipo_1APECEDAPECEDAutoimmunologiczny_zesp%C3%B3%C5%82_niedoczynno%C5%9Bci_wielogruczo%C5%82owej_typu_1%D0%A1%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC_MEDACAPECED_sendromuQ4347774
about
Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigenAutoimmune polyendocrine syndrome type 1: case report and review of literaturePituitary autoantibodies in autoimmune polyendocrine syndrome type 1Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus.New splice site acceptor mutation in AIRE gene in autoimmune polyendocrine syndrome type 1.Cutaneous vasculitis in patients with autoimmune polyendocrine syndrome type 1: report of a case and brief review of the literature.A functional alternative splicing mutation in AIRE gene causes autoimmune polyendocrine syndrome type 1.Identification of endothelin-converting enzyme-2 as an autoantigen in autoimmune polyendocrine syndrome type 1.Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1.Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1.Clonal analysis of regulatory T cell defect in patients with autoimmune polyendocrine syndrome type 1 suggests intrathymic impairment.A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1.Serological proteome analysis reveals new specific biases in the IgM and IgG autoantibody repertoires in autoimmune polyendocrine syndrome type 1.Autoimmune polyendocrine syndrome type 1 in an Indian cohort: a longitudinal study.Altered Immune Activation and IL-23 Signaling in Response to Candida albicans in Autoimmune Polyendocrine Syndrome Type 1Autoimmunity and cystatin SA1 deficiency behind chronic mucocutaneous candidiasis in autoimmune polyendocrine syndrome type 1.The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1.Autoantibodies against aromatic amino acid hydroxylases in patients with autoimmune polyendocrine syndrome type 1 target multiple antigenic determinants and reveal regulatory regions crucial for enzymatic activity.Autoimmune polyendocrine syndrome type 1 (APS I) in Norway.Autoimmune polyendocrine syndrome type 1 in north-western France: AIRE gene mutation specificities and severe forms needing immunosuppressive therapies.Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1.Identification of autoimmune polyendocrine syndrome type 1 in patients with isolated hypoparathyroidism.Introduction: Autoimmune polyendocrine syndrome type 1 (APS-1): a rare monogenic disorder as a model to improve understanding of tolerance and autoimmunity.Rapid whole genome sequencing identifies a novel AIRE variant associated with Autoimmune Polyendocrine Syndrome Type 1.Oral microbiota in autoimmune polyendocrine syndrome type 1.Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: using a new immunoprecipitation assay.Novel neuronal and endocrine autoantibody targets in Autoimmune Polyendocrine Syndrome type 1.A new mutation site in the AIRE gene causes autoimmune polyendocrine syndrome type 1.Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients.Fulminant hepatic failure in autoimmune polyendocrine syndrome type-1.Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.The heterogeneity of autoimmune polyendocrine syndrome type 1: Clinical features, new mutations and cytokine autoantibodies in a Brazilian cohort from tertiary care centersCalcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor ActivityOral Tongue Malignancies in Autoimmune Polyendocrine Syndrome Type 1Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal modelChronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximabTryptophan hydroxylase autoantibodies and intestinal disease in autoimmune polyendocrine syndrome type 1
P921
Q24647314-10430A3D-7830-4D40-9D2A-18CAFB799ABEQ26999696-A77DD664-8C59-437D-8AD5-F0BFA8D25F3FQ33268809-8C2FC8B3-DF38-423C-85AA-4D1B70D6E493Q33322653-69BDFCA9-9D0C-42FC-B925-F91A97792889Q33783895-5EE718C7-9974-457B-8877-8C8D35DD95C2Q33837243-F2F4BBE7-65C9-43A4-A64B-717C2522042CQ34445745-64CD14B3-65DA-4687-8F50-51D0D037AC93Q34559011-5D26ADBC-87FC-4E83-8316-14DCEEEF4A86Q36384776-F9A9F556-E764-4F13-860F-ABC81D0AE3ACQ36527778-62CE6467-E9B2-4DBD-887E-77D9F157FDE9Q37147503-31E91343-7699-4267-878B-CFEE4A8EBED3Q37482693-3DAAE24E-654A-4303-8806-68B717186990Q38665474-2BBB98F0-4397-4AAE-BD1C-87936EBFF8DFQ38999117-859B6DCE-ABAA-4800-9B78-ED2C9E14003BQ40601989-EA800347-02A9-423D-B513-AE9E4C2EFE9FQ41014851-733C86E5-D29F-4BA1-9483-49E238824491Q41619568-B958C63E-C442-4CC6-A75B-B5EA0B2DF4A4Q43672668-A42D7A6F-D14F-4B52-A177-2F0C189B8AB5Q43717357-496C1764-5746-44E1-879F-1F84DA1CF04DQ44320537-4DA879BB-45CE-4AFF-A5CC-07707DD86980Q44931576-BE5BBFD3-A9C6-459D-A939-7BA977DB76C8Q46070817-DD410744-D3EF-4A0B-A856-00BE51E64CC9Q47801340-0BF655AC-D575-4B63-B39D-299A6DDA7CBFQ47871450-59EFD605-D1DD-4B85-9F84-7559DC0A6CA4Q47971028-4F5877C3-9AB7-4FE3-A282-2A62A9B326AAQ50043899-6127BDC9-B30D-471E-A25B-BD197AA8C6D6Q50333123-78C9BCAE-C0EC-47AC-93EE-EAA7EF3702C6Q50947731-0F837945-C040-4AD6-A0BA-D3DED663303CQ50958214-2B3C9717-B1F9-44DC-BD92-C9D42A5DB16CQ50982786-81124CF9-3D25-4FBF-90B8-F807D95A5476Q51359287-461D945B-B6A0-4FFA-AE4B-E8B2A5663A25Q53423562-9A06CA68-440E-4D3D-837D-4E5F9872315FQ55042744-48BD66A8-0BA6-49FE-A027-E50AF3747CB4Q57053791-433C83D0-528A-41DA-B006-15CE2333799DQ58088891-00F9833F-BA21-4701-BC90-F701A09D1772Q58769005-3A0F295E-8FAA-42D8-85EA-1A44ACF3A820Q58855373-C88A4F29-7518-49E8-A71A-97BEFFA8B68EQ59795150-2F0F3BE7-E27F-4F1E-9110-F9CCEB7890BCQ61960512-FA0DF1F2-F96D-4810-B0A4-BC49D822C76FQ61960544-E05066F0-66FA-4793-BDBC-7EAA79B43A1F
P921
description
Krankheit
@de
autoimmune polyendocrine syndr ...... ivity against endocrine organs
@en
аутоимунное заболевание
@ru
name
APECED sendromu
@tr
APECED
@et
APECED
@fi
Autoimmunologiczny zespół niedoczynności wielogruczołowej typu 1
@pl
Poliendocrinopatía autoinmune tipo 1
@es
autoimmune polyendocrine syndrome type 1
@en
polyendocrinopathie auto-immune type 1
@fr
Синдром MEDAC
@ru
متلازمة متعدد الغدد الصم بالمناعة الذاتية النوع الأول
@ar
第一型自體免疫多內分泌症
@zh
type
label
APECED sendromu
@tr
APECED
@et
APECED
@fi
Autoimmunologiczny zespół niedoczynności wielogruczołowej typu 1
@pl
Poliendocrinopatía autoinmune tipo 1
@es
autoimmune polyendocrine syndrome type 1
@en
polyendocrinopathie auto-immune type 1
@fr
Синдром MEDAC
@ru
متلازمة متعدد الغدد الصم بالمناعة الذاتية النوع الأول
@ar
第一型自體免疫多內分泌症
@zh
altLabel
APECED
@pl
Autoimmune Polyglandular Syndrome I
@en
Whitaker syndrom
@en
Zespół APECED
@pl
Zespół Whitakera
@pl
autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
@en
متلازمة المناعة الذاتية ضد الغدد الصماء المتعددة - النوع الأول
@ar
prefLabel
APECED sendromu
@tr
APECED
@et
APECED
@fi
Autoimmunologiczny zespół niedoczynności wielogruczołowej typu 1
@pl
Poliendocrinopatía autoinmune tipo 1
@es
autoimmune polyendocrine syndrome type 1
@en
polyendocrinopathie auto-immune type 1
@fr
Синдром MEDAC
@ru
متلازمة متعدد الغدد الصم بالمناعة الذاتية النوع الأول
@ar
第一型自體免疫多內分泌症
@zh
P6366
P646
P1417
topic/type-1-polyglandular-autoimmune-syndrome
P1995
P2293
P492
P6366
2779714967
P646
/m/05q7j9t
P673
P699
DOID:0050167